What it is
Also known as modified GRF(1-29), it is a stabilized version of the active portion of growth-hormone-releasing hormone and is shorter acting than the DAC form.
CJC-1295 Without DAC5 MGPerformance collection
5 MG per vial · Box of 10
Also known as modified GRF(1-29), this is a stabilized copy of the active portion of growth-hormone-releasing hormone studied for short-acting growth-hormone signaling.
Secure checkout is available through PeptidePay and NOWPayments.
Product guide
Also known as modified GRF(1-29), it is a stabilized version of the active portion of growth-hormone-releasing hormone and is shorter acting than the DAC form.
It is commonly studied alongside ipamorelin in growth-hormone signaling research. The catalogue notes that most human CJC-1295 data concern the longer-acting DAC version rather than this form.
Research-use noticeThis catalogue summary is educational, not medical advice or a recommendation for use. For qualified laboratory research only—not for human, clinical, veterinary, or household use.